Bellevue Group Ag Kura Oncology, Inc. Transaction History
Bellevue Group Ag
- $5.93 Billion
- Q3 2024
A detailed history of Bellevue Group Ag transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 13,600 shares of KURA stock, worth $113,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,600
Previous 10,000
36.0%
Holding current value
$113,560
Previous $205,000
29.27%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KURA
# of Institutions
196Shares Held
84.1MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$63.9 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$58.2 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$48.5 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$45.2 Million1.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$40.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $559M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...